Fox Chase Cancer Center News

PHILADELPHIA (August 14, 2019) — Fox Chase Cancer Center is a proud supporter of the Miles for Melanoma Run/Walk 2019 in Philadelphia, which is presented by the Melanoma Research Foundation (MRF). Faculty and staff, volunteers, patients and survivors, and their families will come together for this family-friendly 5K run/walk to raise funds to support melanoma research, education, and advocacy through MRF.

The event is being held at the Philadelphia Zoo on Saturday, September 7, 2019. Check-in and registration begin at 7 a.m. and the run/walk kicks off at 8:15 a.m.

PHILADELPHIA (August 13, 2019)—Fox Chase Cancer Center is raising awareness about the signs and risk factors for ovarian cancer. According to the American Cancer Society (ACS), ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other cancer of the female reproductive system. The ACS estimates that in 2019, about 22,530 women will receive a new diagnosis of ovarian cancer, and about 13,980 women will die from the disease.

PHILADELPHIA (August 13, 2019) – Fox Chase Cancer Center will launch “Connected by Cancer,” a new narrative podcast, on August 20, 2019.

The seven-part audio documentary will be updated weekly and is available for free on Apple Podcasts, Spotify and other podcasting platforms. Each episode focuses on a different aspect of life at one of the first Comprehensive Cancer Centers designated by the National Cancer Institute including episodes on patients, doctors, researchers, nurses and volunteers.

PHILADELPHIA (August 6, 2019) – Patients with squamous cell carcinoma of the head and neck (HNSCC) may not benefit from high-dose postoperative radiation as compared with standard dosing, according to new research out of Fox Chase Cancer Center.

PHILADELPHIA (July 29, 2019) – Fox Chase Cancer Center has joined a network of leaders organizing across the healthcare industry to bring safety, equity and dignity to their workplaces for women by signing the TIME’S UP Healthcare commitment.

PHILADELPHIA (July 26, 2019) – Shuanzeng Wei, MD, PhD, and colleagues used SNP-based chromosome microarrays to analyze 14 tumor samples taken from patients with low-grade renal cell carcinoma with both clear cell and papillary features. This technology allowed them to perform genome-wide screening and identify genetic copy number variations at a much higher resolution than that of standard or high-resolution chromosome analysis.  

PHILADELPHIA (July 25, 2019) – Researchers at Fox Chase Cancer Center have found that Asf1 recognizes lysine 14 of histone H3 (H3K14) and facilitates the acetylation of H3K56 by the lysine acetyltransferase (KAT) Rtt019-Vps75.

PHILADELPHIA (July 23, 2019) – Fox Chase Cancer Center is pleased to announce the hiring of Fern Anari, MD, who will join the faculty as assistant professor in the Division of Genitourinary Medical Oncology within the Department of Hematology/Oncology.